News & Updates
Filter by Specialty:

Tildrakizumab eases itch, improves life quality in scalp psoriasis
27 Jun 2024
byStephen Padilla
Treatment with tildrakizumab in patients with moderate-to-severe scalp psoriasis helps reduce scalp itch and improve quality of life when compared with placebo, with no new safety signals, as shown in a phase IIIb study.
Tildrakizumab eases itch, improves life quality in scalp psoriasis
27 Jun 2024
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
In patients with type 2 diabetes (T2D), moderate-intensity statin in combination with ezetimibe results in greater reductions in low-density lipoprotein cholesterol (LDL-C) and better prevention of adverse outcomes when compared with high-intensity statin monotherapy, suggests a study.
Statin-ezetimibe combo superior to monotherapy in preventing CVD in T2D patients
27 Jun 2024
Off-label targeted drugs improve survival in CTEPH
26 Jun 2024
Off-label pulmonary arterial hypertension (PAH)-targeted drugs may increase long-term survival in patients with chronic thromboembolic pulmonary hypertension (CTEPH), as shown in a study.